Insulin-like stimulation of cardiac fuel metabolism by physiological levels of glucagon: Involvement of PI3K but not cAMP

American Journal of Physiology - Endocrinology and Metabolism

Volumn 295, Issue 1, 2008, Pages

  Harney, Julie A ^a   Rodgers, Robert L ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Cyclic adenosine monophosphate; Glycolysis; Insulin; Phosphoinositide 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENYLATE CYCLASE; CYCLIC AMP; ENZYME INHIBITOR; GLUCAGON; INSULIN; NKY 80; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; GLUCOSE; MORPHOLINE DERIVATIVE; PALMITIC ACID DERIVATIVE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE OXIDATION; GLYCOLYSIS; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PERFUSION; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART MUSCLE; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ADENYLATE CYCLASE; ANIMALS; BLOTTING, WESTERN; CHROMONES; CYCLIC AMP; GLUCAGON; GLUCOSE; GLYCOLYSIS; INSULIN; MALE; MORPHOLINES; MYOCARDIUM; PALMITATES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 50349088761     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90228.2008     Document Type: Article

References (43)

1. Balks HJ, Jungermann K. Regulation of peripheral insulin/glucagon levels by rat liver. Eur J Biochem 141: 645-650, 1984.
2. Birnbaum M, Fain JN. Activation of protein kinase and glycogen phosphorylase in isolated rat liver cells by glucagon and catecholamines. J Biol Chem 252: 528-535, 1977.
3. Cao W, Collins QF, Becker TC, Robidoux J, Lupo EG, Xiong Y, Daniel KW, Floering L, Collins S. p38 Mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis. J Biol Chem 280: 42731-42737, 2005.
4. Conarello S, Jiang G, Mu J, Li Z, Woods J, Zycband E, Ronan J, Liu F, Roy RS, Zhu L, Charron MJ, Zhang BB. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 50: 142-150, 2007.
5. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oiveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3KPTEN signaling pathways. Cell 110: 737-749, 2002.
6. Davis S. Glucagon. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 2006, p. 1641-1643.
7. Delinsky D, Hill KT, White CA, Bartlett MG. Quantitation of the large polypeptide glucagon by protein precipitation and LC/MS. Biomed Chromatogr 18: 700-705, 2004.
8. Evans M, Hopkins D, Macdonald IA, Amiel SA. Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects. Diabet Med 21: 440-446, 2004.
9. Exton J, Robison GA, Sutherland EW, Park CR. Studies on the role of adenosine 3′,5′-monophosphate in the hepatic actions of glucagon and catecholamines. J Biol Chem 246: 6166-6177, 1971.
10. Gelling R, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, Johansen PB, Rossetti L, Jelicks LA, Serup P, Nishimura E, Charron MJ. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100: 1438-1443, 2003.
11. Gerich J. Physiology of glucagon. Int Rev Physiol 24: 243-275, 1981.
12. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28: 84-116, 2007.
13. Hermsdorf T, Dettmer D, Hofmann E. Age-dependent effects of phorbol ester on adenylate cyclase stimulation by glucagon in liver of female rats. Biomed Biochim Acta 48: 255-260, 1989.
14. Houslay M. Compartmentalization of cyclic AMP phosphodiesterases, signalling 'crosstalk', desensitization and the phosphorylation of Gi-2 add cell specific personalization to the control of the levels of the second messenger cyclic AMP. Adv Enzyme Regul 35: 303-338, 1995.
15. Ikezawa Y, Yamatani K, Ogawa A, Ohnuma H, Igarashi M, Daimon M, Manaka H, Sasaki H. Effects of glucagon on glycogenolysis and gluconeogenesis are region-specific in periportal and perivenous hepatocytes. J Lab Clin Med 132: 547-555, 1998.
16. Inouye K, Shum K, Chan O, Mathoo J, Matthews SG, Vranic M. Effects of recurrent hyperinsulinemia with and without hypoglycemia on counterregulation in diabetic rats. Am J Physiol Endocrinol Metab 282: E1369-E1379, 2002.
17. Jaspan J, Ruddick J, Rayfield E. Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver. J Clin Endocrinol Metab 58: 287-292, 1984.
18. Jelinek L, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA, O'Hara PJ, Foster D, Walker KM, Chen LHJ, McKernan PA, Kindsvogel W. Expression cloning and signaling properties of the rat glucagon receptor. Science 259: 1614-1616, 1993.
19. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284: E671-E678, 2003.
20. Kreisberg R, Williamson JR. Metabolic effects of glucagon in the perfused rat heart. Am J Physiol 207: 721-727, 1964.
21. Lefebvre V, Mechin MC, Louckx MP, Rider MH, Hue L. Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin. J Biol Chem 271: 22289-22292, 1996.
22. Li X, Carretero OA, Shao Y, Zhuo JL. Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C. Hypertension 47: 580-585, 2006.
23. Livingston J, Einarsson K, Backman L, Ewerth S, Arner P. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects. J Clin Invest 75: 397-403, 1985.
24. Marliss E, Aoki TT, Unger RH, Soeldner JS, Cahill GF Jr. Glucagon levels and metabolic effects in fasting man. J Clin Invest 49: 2256-2270, 1970.
25. Matsui T, Rosenzweig A. Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38: 63-71, 2005.
26. Méry P, Brechler V, Pavoine C, Pecke F. Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature 345: 158-161, 1990.
27. Murad F, Vaughan M. Effect of glucagon on rat heart adenyl cyclase. Biochem Pharmacol 18: 1053-1059, 1969.
28. Murphy G, Hruby VJ, Trivedi D, Wakelam MJ, Houslay MD. The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism. Biochem J 243: 39-46, 1987.
29. Oudit G, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37: 449-471, 2004.
30. Parker J, Andrews KM, Allen MR, Stock JL, McNeish JD. Glycemic control in mice with targeted disruption of the glucagon receptor gene. Biochem Biophys Res Commun 290: 839-843, 2002.
31. Raju B, Cryer PE. Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am J Physiol Endocrinol Metab 289: E181-E186, 2005.
32. Rall T, Sutherland EW, Berthet J. The relationship of epinephrine and glucagon to liver phosphorylase. IV. Effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem 224: 463-475, 1957.
33. Ramachandran C, Angelos KL, Walsh DA. Cyclic AMP-dependent and cyclic AMP-independent antagonism of insulin activation of cardiac glycogen synthase. J Biol Chem 257: 1448-1457, 1982.
34. Rodgers R, Christe ME, Tremblay GC, Babson JR, Daniels T. Insulin-like effects of a physiologic concentration of carnitine on cardiac metabolism. Mol Cell Biochem 226: 97-105, 2001.
35. Rodgers R, MacLeod KM, McNeill JH. Responses of rat and guinea pig hearts to glucagon. Lack of evidence for a dissociation between changes in myocardial cyclic 35-adenosine monophosphate and contractility. Circ Res 49: 216-225, 1981.
36. Sandoval D, Ping L, Neill RA, Morrey S, Davis SN. The effects of dehydroepiandrosterone sulfate on counterregulatory responses during repeated hypoglycemia in conscious normal rats. Diabetes 53: 679-686, 2004.
37. Sørensen H, Winzell MS, Brand CL, Fosgerau K, Gelling RW, Nishimura E, Ahren B. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function. Diabetes 55: 3463-3469, 2006.
38. Sugden M, Orfali KA, Fryer LG, Holness MJ, Priestman DA. Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase: regulation by insulin, cyclic AMP and pyruvate. J Mol Cell Cardiol 29: 1867-1875, 1997.
39. Sutherland E. Studies on the mechanism of hormone action. Science 177: 401-408, 1972.
40. Toker A, Cantley LC. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673-676, 1997.
41. Unson CG, Gurzenda EM, Merrifield RB. Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist. Peptides 10: 1171-1177, 1989.
42. Wakelam M, Murphy GJ, Hruby VJ, Houslay MD. Activation of two signal-transduction systems in hepatocytes by glucagon. Nature 323: 68-71, 1986.
43. Zhao A, Shinohara MM, Huang D, Shimizu M, Eldar-Finkelman H, Krebs EG, Beavo JA, Bornfeldt KE. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 275: 11348-11354, 2000.